1. Ryaltris Approved Product Information. 2. Gross GN et al. Ann Allergy Asthma Immunol 2019;122:630-638. 3. Hampel FC et al. Allergy Asthma Proc 2019;40(4):261-272. 4. Segall N et al. Allergy Asthma Proc 2019;40(5):301-310.
Ryaltris: Your combination to offer patients relief from the symptoms of Allergic Rhinitis - Fast*1-4
* NEW fixed dose combination of mometasone furoate and olopatadine hydrochloride indicated for symptomatic treatment of seasonal or perennial allergic rhinitis and associated ocular symptoms in adults and children of 6 years and older.
Provides greater relief from allergic rhinitis symptoms than its monocomponents.
Provides relief from ocular symptoms of allergic rhinitis.
Fast onset of action.
Well tolerated and in a familiar plastic bottle.